Thrombin-induced, TNFR-dependent miR-181c downregulation promotes MLL1 and NF-κB target gene expression in human

Min Yin1, Zhiying Chen2, Yetong Ouyang1

  • 1Department of Neurology, The Second Affiliated Hospital of Nanchang University, No. 1 Minde Road, Nanchang, 330006, Jiangxi Province, China.

Abstract

Insights

MicroRNA-181c (miR-181c) downregulation promotes inflammation in brain injury by increasing MLL1 expression and NF-κB activity. Restoring miR-181c levels may offer a novel therapy for intracerebral hemorrhage (ICH).

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Microglial activation by thrombin is a key factor in intracerebral hemorrhage (ICH) pathogenesis.
  • Targeting thrombin-driven microglial activation presents a potential therapeutic strategy for ICH.

Purpose of the Study:

  • To investigate the role of microRNA (miRNA)-based regulation in thrombin-induced microglial activation.
  • To identify specific miRNAs involved in the inflammatory response following ICH.

Main Methods:

  • Utilized an in vitro model of thrombin-induced microglial activation using primary human microglia.
  • Employed miRNA array, qRT-PCR, luciferase reporter assays, and gene silencing techniques.
  • Assessed the impact of miR-181c on MLL1 expression and NF-κB signaling pathways.

Main Results:

  • Thrombin exposure led to miR-181c downregulation and MLL1 upregulation, dependent on TNF-α/TNFR signaling.
  • miR-181c was confirmed to directly target and downregulate MLL1 expression.
  • Thrombin increased NF-κB activity, while miR-181c mimic transfection reduced it.

Conclusions:

  • Thrombin-induced miR-181c downregulation promotes MLL1 expression and enhances pro-inflammatory NF-κB activity.
  • miR-181c acts as a negative regulator of thrombin-driven microglial activation.
  • miR-181c mimic therapy holds promise for managing ICH by controlling microglial inflammation.

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.1K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.7K